Clinical Trials Browser

Phase 1 × Has results × Paclitaxel × Clear all

Carcinoma, Squamous Cell, Neoplasms, Squamous Cell

Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Solid Tumors

Locally Advanced and Metastatic Solid Tumors

Breast Neoplasms

Anatomic Stage I Breast Cancer AJCC v8

Ovarian Neoplasms

Squamous-Cell Non-Small-Cell Lung Cancer

Breast Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Carcinosarcoma

Uterine Cervical Neoplasms, Camurati-Engelmann Syndrome

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

Advanced Solid Neoplasm

Carcinoma, Non-Small-Cell Lung, Neoplasms

Advanced Solid Neoplasm

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms, Stomach Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasms, Respiratory Tract Neoplasms

Solid Tumors

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

Non-hematologic Malignancy

Advanced Nonhematologic Malignancies

Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Hematologic Neoplasms

Advanced Solid Tumours

Ovarian Neoplasms, Small Cell Lung Carcinoma

Solid Malignancies

Advanced Solid Tumours

Advanced Solid Tumors

Advanced Malignant Solid Tumors

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

Glioma, Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer

A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer

Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer

Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer

FORTITUDE-201

A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

MK-3475 Immunotherapy in Endometrial Carcinoma

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

MK-4440-001

A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

MK-3475-434

A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors

A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel

Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)

A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery

KEYNOTE 173

CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)

Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies

A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies

A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors

MK-2206-003

A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer

Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC

Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling

Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.

Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors

14C

Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours

Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors

Study Evaluating Safety And Tolerability, Solid Tumor

Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors

Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer

Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours

Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)